MedMountain Ventures
Seed–Series A
Investment thesis
MMV targets healthcare companies that demonstrate measurable impact on patient outcomes at scale through transformative rather than incremental solutions. The firm prioritizes clinical AI, diagnostics, telehealth platforms, and care delivery innovations. Drawing on founder-physicians' frontline experience, the firm provides deep clinical expertise, operator networks, and hands-on support to navigate healthcare's regulatory and operational complexity. Investment thesis emphasizes companies capable of structural change in how care is delivered, financed, and accessed, backed by teams with proven ability to execute in regulated healthcare environments.
Source: firm website, verified Jul 19, 2026.
What they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Enterprise Software ×1Fintech ×1SaaS ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathConfido provides AI-powered automation for cash application, deduction management, and dispute resolution on a single platform, designed specifically for accounting teams at consumer packaged goods (CPG) brands.
AI & Machine LearningEnterprise SoftwareFintechSaaSNew York City, US
Frequently asked questions
- What stage does MedMountain Ventures invest at?
- MedMountain Ventures invests at the Seed, Series A stages.
- What sectors does MedMountain Ventures focus on?
- MedMountain Ventures focuses on AI & Machine Learning, Digital Health, Healthtech, Medical Devices.
Similar investors
Breyer Capital invests in breakthrough biomedical technologies, emerging models of care, and economic systems that drive sustainable healthcare transformation. The firm partners early and deeply with entrepreneurs across AI-first diagnostics, programmable medicines, data infrastructure, financial systems, clinician software, and novel care delivery models.
Data Collective identifies and supports ambitious company founders developing technology-driven solutions. The firm focuses on companies using innovation to restore predictability in an unstable world, with demonstrated expertise across clean energy, gene therapy, sustainable agriculture, and machine learning applications in healthcare.
Google Ventures invests in innovative founders across diverse industries, focusing on companies where they can provide value across multiple stages and milestones through long-term relationships.
Innovestor is a Nordic investment group active across early-stage platforms including Angel CoFund, Life Science Fund, and Growth Fund III. The firm completed 74 investments in 2025 (23 initial and 51 follow-on rounds) and achieved a €24 million real estate exit. Innovestor also operates Energy Storage and Corporate Venturing investment platforms.
Karma invests in deep tech companies in Europe, backing 26 portfolio companies with initial cheques of €1-5M and managing €170M in assets.